# Freed

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/freed-2

- Industry: Software
- Headquarters: San Francisco, US
- Website: www.getfreed.ai
- Total disclosed funding: $30M
- Latest round: Series A (Mar 5, 2025)
- Investors on record: 2

## About

Freed Inc. is an innovative company that specializes in AI-driven solutions for healthcare documentation, specifically focusing on enhancing clinician efficiency and accuracy through intelligent transcription services.Founded in 2023 in San Francisco, US, Freed Inc. develops an AI-powered scribe designed to streamline documentation for healthcare professionals. The company has successfully completed one funding round, raising USD 30.00 mn in Series A funding led by Sequoia Capital with participation from Scale Venture Partners. The founder's background is not explicitly mentioned, nor are there details of any previous companies founded by them.Freed offers a core product that functions as an AI scribe designed to streamline the documentation process for clinicians across various specialties. This AI-powered tool listens, transcribes, and generates medical notes, specifically formatted as SOAP notes, essential for clinical record-keeping. The service is tailored to learn individual clinician styles over time, improving the customization of notes produced. Freed’s technology is beneficial for podiatrists, primary care physicians, psychiatrists, and other medical professionals, enabling them to focus more on patient interactions rather than administrative tasks. The product is available in multiple languages, catering to a diverse client base, and is accessible to clinicians in the United States and potentially other regions where English is commonly spoken in healthcare settings.Freed generates revenue primarily through a subscription-based model, offering individual and group pricing plans. The individual subscription is priced at USD 99.00 per month, providing unlimited visits and the flexibility to cancel anytime, while group pricing structures are customized based on organizational needs and licensing requirements. The service allows clinicians to try the AI scribe with a free seven-day trial, enhancing user engagement and acquisition. Transactions typically involve direct relationships between Freed and healthcare professionals or organizations, facilitating seamless integration of the AI scribe into existing workflows. By providing a solution that aims to reduce documentation time, Freed enhances the overall efficiency of clinical operations, positioning itself favorably in the healthcare technology market.In March 2025, Freed Inc. raised USD 30.00 mn in Series A funding led by Sequoia Capital, with additional participation from Scale Venture Partners. The company will use the funding to develop its artificial intelligence-based healthcare technology. Freed is focused on designing new features and expanding its product offerings, with an aim to enter additional markets by 2026, specifically targeting regions in Europe and Asia where demand for AI in healthcare documentation is increasing.

## Funding rounds

- Series A, Mar 5, 2025, $30M — Hong Shan, Scale Venture Partners

## Investors

- Hong Shan — Series A
- Scale Venture Partners (https://capitalatlas.ai/funds/scale-venture-partners) — Series A